IS JAK2 V617F GENE POINT MUTATION A RISK FACTOR FOR BLEEDING OR THROMBOSIS IN PATIENTS WITH MYELOPROLIFERATIVE DISEASE?

Bilgin, A. UgurYildirim, M.2024-02-232024-02-2320120390-6078https://hdl.handle.net/20.500.12452/17493[Abstract Not Availabe]eninfo:eu-repo/semantics/closedAccess[Keyword Not Available]IS JAK2 V617F GENE POINT MUTATION A RISK FACTOR FOR BLEEDING OR THROMBOSIS IN PATIENTS WITH MYELOPROLIFERATIVE DISEASE?Conference Object97642642Q1WOS:000496830406150